SSSetareh Shojaei

Setareh Shojaei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Setareh Shojaei has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Flavonoids as Promising Akt1 Inhibitors in Cancer Medicine: Insights From Molecular Docking, Dynamics, DFT Calculations, and In Vitro Validation

    by Shokoofeh Jamshidi, Ali Eghbalian, Setareh Shojaei, Amir Taherkhani, Mehran Feizi‐Dehnayebi

    Background: The PI3K/Akt/mTOR signaling pathway is commonly deregulated in different types of cancers, contributing to tumor proliferation, persistence, and resistance to treatment. Akt1, a crucial kinase within this pathway, plays a critical role in tumor progression and the occurrence of therapeutic resistance. The emergence of resistance is a significant challenge in cancer therapy. Targeted therapies offer a promising method to overcome this challenge. Akt1 presents a promising target for therapeutic intervention.Aims: This study aimed to evaluate the binding affinities of 61 flavonoid‐derived natural compounds to the Akt1 ATP‐binding site using molecular docking with AutoDock to identify potential Akt1 inhibitors.Methods: Cross‐validation and Density Functional Theory analysis were conducted utilizing the SwissDock server and the Gaussian 09 W software suite for the top‐ranked compounds. Following energy minimization, semi‐flexible docking of flavonoids and the control inhibitor Ipatasertib was performed against the Akt1 ATP‐binding pocket. Binding modes were analyzed using Discovery Studio Visualizer. Molecular dynamics simulations were conducted to assess the conformational stability and binding durability of the highest‐scoring Akt1 inhibitor complex identified through molecular docking analyses. The pharmacokinetics and toxicity properties of the most potent Akt1 inhibitors were evaluated using the PreADMET tool. Also, the effect of the most potent Akt1 inhibitor on cell viability was studied in vitro through the 2,5‐diphenyl‐2H‐tetrazolium bromide approach. Besides, the most promising compound was evaluated for its impact against the FOXO3 (an Akt1 downstream target) gene expression in MCF‐7 cells.Results: Kaempferol 3‐rutinoside‐4′‐glucoside and Kaempferol 3‐rutinoside‐7‐sophoroside displayed exceptional binding affinities (ΔGbinding = −21.79 and −20.73 kcal/mol; Ki = 106.03 aM and 640.24 aM), surpassing Ipatasertib (ΔGbinding = −9.98 kcal/mol; Ki = 48.29 nM). Kaempferol 3‐rutinoside‐4′‐glucoside achieved a stable binding conformation within the Akt1 catalytic domain after 30 ns of molecular dynamics simulation. The compound Kaempferol 3‐rutinoside‐4′‐glucoside was observed to suppress cell proliferation in MCF‐7 cell lines. This effect was accompanied by an upregulation of FOXO3 expression, suggesting a connection to the induction of the apoptosis pathway.Conclusions: Computational analyses identified flavonoids, particularly Kaempferol glycosides, as potential Akt1 inhibitors with significantly higher predicted binding affinities than Ipatasertib. These findings warrant further exploration of the therapeutic potential of flavonoids for cancers driven by Akt1 hyperactivation.


  • A comparative evaluation of the efficacy of three commonly used diode lasers (810, 940, and 980-nanometer) to solder skin incisions: an experimental study in the rat

    by Mohammad Reza Jamalpour, Hamid Naderi, Shokoofeh Jamshidi, Salman Khazaei, Setareh Shojaei

    The evolution of wound closure methods has led to the exploration of new and improved techniques such as laser tissue soldering. This study aimed to compare the effects of 810, 940, and 980 nm diode lasers and suturing to identify the most effective wavelength for soldering skin incisions. Three sets of incisions were bound on the backs of 63 rats using diode lasers and sutures. A combination of bovine serum albumin (50%), indocyanine green, and sodium hyaluronate was used as a solder. Healing progress was assessed on the 1st, 4th, 7th, 14th, and 21st days after surgery through histological examination and measurements of tensile strength. Although immediate superficial closure was found for the laser-bonded incisions, on the 4th day, the entire thickness of the incision was closed only in the 810 nm laser group. Thermal damage was observed for all the laser-irradiated groups. For the sutured group, the incisions remained unclosed for the first day, and openings through the incision were observed. The incisions treated with a 980 nm laser had the highest amount of tensile strength. At the end of the 21-day recovery period, no significant differences between experimental groups were observed in terms of the histological and tensile strength values. All studied diode lasers can effectively repair incisions similar to a suture, but the 980 nm treated incisions will be significantly more resistant to mechanical tension. The 810 nm diode laser demonstrated the earliest wound closure, which could benefit areas requiring more aesthetic consideration.


  • Open Access

    Rational Design and In Silico Evaluation of a Multiepitope Vaccine Targeting the uPAR for Cancer Immunotherapy

    by Fahimeh Baghaei, Zahra Hemmat, Amir Taherkhani, Setareh Shojaei, Ali Teimoori

    Background: The urokinase plasminogen activator receptor (uPAR) plays a crucial role in cancer development and progression, making it an attractive target for immunotherapeutic strategies. This study aimed to develop a multiepitope vaccine targeting uPAR by incorporating T cell epitopes and a toll‐like receptor 4 (TLR4) agonist as an adjuvant. Methods: Immunoinformatics approaches were employed to predict and select immunogenic epitopes from the uPAR protein sequence. The selected epitopes were assembled into a multiepitope vaccine construct, including a TLR4 agonist derived from Mycobacterium tuberculosis as an adjuvant. The vaccine candidate underwent comprehensive in silico analyses, including antigenicity, allergenicity, physicochemical properties, and structural modeling. Molecular docking and molecular dynamics (MD) simulations were performed to evaluate the vaccine’s interaction with the TLR4 receptor and assess its structural stability. Also, vector design was performed using the SnapGene software, while immune response simulations were conducted with the C‐ImmSim server. Results: The multiepitope vaccine construct comprised five cytotoxic T lymphocyte (CTL) epitopes, five helper T lymphocyte (HTL) epitopes, and the TLR4 agonist adjuvant. The vaccine was predicted to be nonallergenic, antigenic, and soluble, with favorable physicochemical properties. Molecular docking analysis revealed a strong binding affinity between the vaccine and TLR4, with a docking score of −334.37kcal/mol. MD simulations demonstrated the structural stability and rigidity of the vaccine–TLR4 complex. The computational immune simulation predicted a strong vaccine response with lasting antibody production, robust cellular immunity, and immunological memory formation. Conclusion: The proposed multiepitope vaccine construct, consisting of carefully selected uPAR epitopes and a potent adjuvant, exhibits promising characteristics for inducing a robust immune response against cancer cells expressing uPAR. The favorable in silico results warrant further experimental validation and preclinical studies to assess the vaccine’s efficacy and potential as a cancer immunotherapeutic agent.


  • Open Access

    Natural Anthraquinones as Potential Akt1-Targeted Anticancer Agents

    by Shokoofeh Jamshidi, Fatemeh Mahfouzi, Setareh Shojaei, Amir Taherkhani

    Background: The phosphoinositide 3-kinase/protein kinase B (Akt)/mammalian target of the rapamycin signaling pathway is crucial in cancer progression. Akt1, a vital pathway component, has emerged as a promising therapeutic target. Objectives: This study used molecular docking analysis to investigate the potential of anthraquinones (AQs) as Akt1 inhibitors. Methods: The crystallographic structure of Akt1 was obtained from the Protein Data Bank (PDB ID: 4GV1). Twenty-one AQ compounds were selected for docking analyses using AutoDock 4.0. Binding affinities and interaction modes were compared with two Akt1 reference inhibitors. Results: Eleven AQs demonstrated substantial binding affinity to the Akt1’s catalytic site at nanomolar concentrations. Hypericin and sennidin B exhibited the most potent inhibitory effects, with ΔGbinding values of -11.19 kcal/mol and -10.36 kcal /mol, respectively, surpassing control inhibitors. Hypericin formed three hydrogen bonds and two hydrophobic interactions with the Akt1 catalytic cleft, while sennidin B formed six hydrogen and one hydrophobic interaction. Conclusion: This study identified several AQs, particularly hypericin and sennidin B, as promising Akt1 inhibitors with superior binding affinities compared to reference compounds. These findings provide a foundation for further developing AQ-based Akt1-targeted therapeutics in cancer treatment. Future research should focus on the in vitro and in vivo validation of these compounds’ efficacy and safety profiles.


  • Open Access

    Therapeutic Targeting of Akt1 in Oral Squamous Cell Carcinoma Using Natural Cinnamic Acids

    by Setareh Shojaei, Amirhoseyn Naiini, Shokoofeh Jamshidi, Amir Taherkhani

    Background: Akt1, a serine/threonine kinase, plays a central role in cancer development and progression. Its overexpression correlates with aggressive phenotypes and poor prognosis in several types of cancers, such as oral squamous cell carcinoma (OSCC). Cinnamic acid derivatives (CADs) from natural sources exhibit anticancer properties, making them potential Akt1 inhibitors. Methods: The binding affinities of 19 CADs to the Akt1 catalytic cleft were evaluated using molecular docking simulations and then compared with the Akt1 inhibitor capivasertib. Interaction modes were analyzed to identify critical residues involved in ligand binding. Results: Cynarin demonstrated the highest binding affinity (ΔGbinding =-13.46 kcal/mol, Ki=136.48 pM), forming three hydrogen bonds with Akt1. Rosmarinic acid with six hydrogen bonds also exhibited potent inhibition (ΔGbinding =-11.51 kcal/mol , Ki=3.67 nM). Both compounds represented superior binding compared to capivasertib. Conclusion: Cynarin and rosmarinic acid from natural sources showed promising inhibitory potential against Akt1, suggesting their therapeutic values as anticancer agents targeting the PI3K/Akt pathway in OSCC.

  • Open Access

    Exploring Cinnamic Acids as Potent Antimetastatic Agents for Cancer Therapy: Molecular Docking and Dynamic Simulation against MMP2

    by Setareh Shojaei, Mohammad-Reza Zandieh, Shokoofeh Jamshidi, Amir Taherkhani, Zahra Azadian

    Objective. Matrix metalloproteinase-2 (MMP2) overexpression has been considered as a hallmark of tumor aggressiveness. The significant roles of MMP2 in other human disorders, such as cardiovascular diseases and dental caries, have also been demonstrated. Herein, we used in silico approaches to evaluate the binding affinity of selected cinnamic acids to the MMP2 catalytic domain. The obtained findings were subsequently juxtaposed with those attributed to oleandrin, utilized as a reference pharmaceutical agent. Methods. This research employed the AutoDock software to assess the affinity of 19 herbal compounds derived from cinnamic acid to the catalytic cleft of MMP2. The ligands attaining the most negative scores, as determined by the Gibbs free binding energy assessments, were accorded the highest rankings. The interactions between the MMP2 and cinnamic acids ranked highest were elucidated using the Discovery Studio Visualizer tool. Molecular dynamics simulations were performed to investigate the structural stability of MMP2 backbone atoms when forming complexes with both the top-ranked inhibitor from this study and a standard drug. Results. Eight cinnamic acids were indicated with values less than −10 kcal/mol. Cynarin emerged as the most potent inhibitor of the enzyme, with the score and inhibition constant value of −15.19 kcal/mol and 7.29 pM, respectively. The MMP2 backbone atoms achieve stability around the 20 ns mark, displaying a root mean square deviation of approximately 3.2 Å when influenced by the top-ranked cinnamic acid, the standard drug, or in their free form. Conclusion. The inhibition of MMP2 by cinnamic acids, particularly cynarin, holds promise as a valuable therapeutic strategy for various human disorders, encompassing cancer, cardiovascular conditions, and dental caries.


  • Open Access

    Malignant Transformation of Normal Oral Tissue to Dysplasia and Early Oral Squamous Cell Carcinoma: An In Silico Transcriptomics Approach

    by Shokoofeh Jamshidi, Matina Tavangar, Setareh Shojaei, Amir Taherkhani

    Background: Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive form of head and neck cancer, often diagnosed at advanced stages. Elucidating the molecular mechanisms involved in the malignant transformation from normal oral tissue to oral preinvasive lesions (OPL) and primary OSCC could facilitate early diagnosis and improve therapeutic strategies.Methods: Differentially expressed genes (DEGs) were identified from the GSE30784 dataset by comparing normal oral tissue, oral dysplasia, and primary OSCC samples. Cross‐validation was performed using an independent RNA‐seq dataset, GSE186775. Protein–protein interaction (PPI) network analysis, gene ontology annotation, and pathway enrichment analysis were conducted on the common DEGs. Hub genes were identified, and their prognostic significance was evaluated using survival analysis. Transcription factor (TF) enrichment analysis, cross‐validation, and immunohistochemistry analyses were also performed.Results: A total of 226 proteins and 677 interactions were identified in the PPI network, with 34 hub genes, including FN1, SERPINE1, PLAUR, THBS1, and ITGA6. Pathways such as “Formation of the cornified envelope,” “Keratinization,” and “Developmental biology” were enriched. Overexpression of SERPINE1, PLAUR, THBS1, and ITGA6 correlated with poor prognosis, while upregulation of CALML5 and SPINK5 was associated with favorable outcomes. NFIB emerged as the most significant TF‐regulating hub genes. Immunohistochemistry validated ITGA6 overexpression in primary OSCC. Cross‐validation using the RNA‐seq dataset supported the involvement of critical genes in the malignant transformation process.Conclusion: This study identified vital genes, pathways, and prognostic markers involved in the malignant transformation from normal oral tissue to OPL and primary OSCC, providing insights for early diagnosis and targeted therapy development. Cross‐validation with an independent RNA‐seq dataset and immunohistochemistry reinforced the findings, supporting the robustness of the identified molecular signatures.


  • Exploring natural anthraquinones as potential MMP2 inhibitors: A computational study

    by Shokoofeh Jamshidi, Ali Rostami, Setareh Shojaei, Amir Taherkhani, Heshmatollah Taherkhani


  • Open Access

    MicroRNA-Based Markers of Oral Tongue Squamous Cell Carcinoma and Buccal Squamous Cell Carcinoma: A Systems Biology Approach

    by Setareh Shojaei, Pouya Menbari, Shokoofeh Jamshidi, Amir Taherkhani

    Objective. Oral tongue squamous cell carcinoma (OTSCC) and buccal squamous cell carcinoma (BSCC) are the first and second leading causes of oral cancer, respectively. OTSCC and BSCC are associated with poor prognosis in patients with oral cancer. Thus, we aimed to indicate signaling pathways, Gene Ontology terms, and prognostic markers mediating the malignant transformation of the normal oral tissue to OTSCC and BSCC. Methods. The dataset GSE168227 was downloaded and reanalyzed from the GEO database. Orthogonal partial least square (OPLS) analysis identified common differentially expressed miRNAs (DEMs) in OTSCC and BSCC compared to their adjacent normal mucosa. Next, validated targets of DEMs were identified using the TarBase web server. With the use of the STRING database, a protein interaction map (PIM) was created. Using the Cytoscape program, hub genes and clusters within the PIM were shown. Next, gene-set enrichment analysis was carried out using the g:Profiler tool. Using the GEPIA2 web tool, analyses of gene expression and survival analysis were also performed. Results. Two DEMs, including has-miR-136 and has-miR-377, were common in OTSCC and BSCC ( value 1). A total of 976 targets were indicated for common DEMs. PIM included 96 hubs, and the upregulation of EIF2S1, CAV1, RAN, ANXA5, CYCS, CFL1, MYC, HSP90AA1, PKM, and HSPA5 was significantly associated with a poor prognosis in the head and neck squamous cell carcinoma (HNSCC), while NTRK2, HNRNPH1, DDX17, and WDR82 overexpression was significantly linked to favorable prognosis in the patients with HNSCC. “Clathrin-mediated endocytosis” was considerably dysregulated in OTSCC and BSCC. Conclusion. The present study suggests that has-miR-136 and has-miR-377 are underexpressed in OTSCC and BSCC than in normal oral mucosa. Moreover, EIF2S1, CAV1, RAN, ANXA5, CYCS, CFL1, MYC, HSP90AA1, PKM, HSPA5, NTRK2, HNRNPH1, DDX17, and WDR82 demonstrated prognostic markers in HNSCC. These findings may benefit the prognosis and management of individuals with OTSCC/BSCC. However, additional experimental verification is required.


  • Open Access

    A Policy Brief on Improving the Prognosis of Patients With Oral Squamous Cell Carcinoma

    by Amir Taherkhani, Zohre Farhadi, Shahab Shahmoradi Dehto, Shokoofeh Jamshidi, Zeynab Bayat, Setareh Shojaei

    A Policy Brief on Improving the Prognosis of Patients With Oral Squamous Cell Carcinoma